Skip To Main Content
Healthcare Professionals Site

Prescribing Information

Resources to download

Helpful tools designed to support your IPF journey

It helps to have information and tools that are designed for the specific needs of a patient with idiopathic pulmonary fibrosis (IPF).

The following materials can help answer questions about Esbriet® (pirfenidone) and give you additional support—so you can make the most of your treatment with Esbriet.

You can download these resources to your computer or print them out.

Información en Español >

View Download

  • Recipe Cards

    These recipe cards are made to be quick and easy meal options you can cook. They can be a good starting point when thinking of a meal plan to have during your Esbriet treatment. Talk to your doctor about the kind of meals and diet that are right for you.
    View
    Download

  • What's Next Brochure | Esbriet® (pirfenidone) HCP

    Use this brochure to help walk your patients through what to expect after being prescribed Esbriet, including important actions and information.
    View
    Download

  • Tracking Your Journey Journal

    The journal is designed to help you and your doctor keep track of your treatment with Esbriet. There are places to write down activities and life events.
    View
    Download
Download Selected 0 files selected Files will be downloaded as .zip file.

  • Complete and submit a form electronically.

For more educational and support resources, please enroll in the Esbriet® Inspiration Program™, or call 1-844-My Esbriet to request materials

About Esbriet

Esbriet® (pirfenidone) is a prescription medicine used to treat people with a lung disease called idiopathic pulmonary fibrosis (IPF).

It is not known if Esbriet is safe and effective in children.

Before you take Esbriet, tell your doctor if you:
  • have other medical conditions (particularly liver or kidney problems).
  • are a smoker.
  • are or plan to become pregnant or breastfeed (Esbriet has not been studied in these patients).
  • are taking any prescription or over-the-counter medicines, vitamins, or herbal supplements.
What are the possible side effects of Esbriet?

Esbriet may cause serious side effects, including:

  • liver problems. Call your doctor if you have symptoms such as yellowing of your skin or eyes, dark or brown urine, pain on the upper right side of your stomach area, bleeding or bruising more easily than normal, or increased fatigue. Your doctor will also do regular blood tests to check your liver.
  • sun sensitivity and rash. When you are outside, use sunscreen (SPF 50) and wear a hat and clothes that cover your skin to avoid getting a sunburn.
  • stomach problems. Esbriet may cause stomach problems such as nausea, vomiting, diarrhea, indigestion, heartburn, and stomach pain.

Your doctor may change your dose or discontinue Esbriet if side effects do not go away.

The most common side effects of Esbriet include upper respiratory tract infections, feeling tired, headache, dizziness, loss of appetite, sinusitis, insomnia, or weight loss.

These are not all the possible side effects of Esbriet.

What should you avoid while taking Esbriet?
  • Direct exposure to sunlight, or light from sunlamps and tanning beds.
  • Other medicines that can make your skin sensitive to sunlight.
  • Smoking, which may affect how well Esbriet works.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch or to Genentech at 1-888-835-2555.

Please see full Prescribing Information, including Patient Information, for additional important safety information.

    • Centers for Medicare & Medicaid Services. Advance notice of methodological changes for calendar year (CY) 2018 for Medicare Advantage (MA) capitation rates, Part C and Part D payment policies and 2018 call letter. https://www.cms.gov/Medicare/Health-Plans/MedicareAdvtgSpecRateStats/Downloads/Advance2018.pdf. Posted February 1, 2017. Accessed October 17, 2017.

      Centers for Medicare & Medicaid Services. Advance notice of methodological changes for calendar year (CY) 2018 for Medicare Advantage (MA) capitation rates, Part C and Part D payment policies and 2018 call letter. https://www.cms.gov/Medicare/Health-Plans/MedicareAdvtgSpecRateStats/Downloads/Advance2018.pdf. Posted February 1, 2017. Accessed October 17, 2017.